Hyperbaric Medicine Operations and Management Services
At Life-Support Technologies group we recognize our clients have different on-site support needs and program goals. Therefore, we have developed and offer two different programs tailored to provide hospital-based services at a level that best fits your objectives. Every LST program includes a hyperbaric chamber and an ancillary equipment package complete with all emerging and annual planned maintenance throughout the contract period so that you only have one annual flat fee. Whichever program you may choose, the result will be an increasing Revenue stream and improved clinical outcomes.
Hyperbaric Chamber Equipment and Consulting Support Program
This, zero-risk, fixed-fee program is designed to complement, expand and support an existing Wound Care Program. LST provides all of the equipment, software and on-offsite training necessary to provide YOUR staff with the capability, skills and confidence needed to successfully operate a safe, efficient, and cost effective adjunctive hyperbaric service. The result is the same clinically and financially successful hyperbaric oxygen therapy service as found in the full, turn-key, LST contract management operations referred to below - only operated and managed by YOUR LST-trained staff. LST specialists provide ongoing support throughout the contract period to optimize performance.
Hyperbaric Medicine Management and Staffing Program
This zero-risk, fixed-fee, hyperbaric management program is designed to compliment, expand and support an existing Wound Care Program. LST will furnish your hospital with the equipment and personnel necessary to help improve an existing chronic wound program and operate the hyperbaric medicine operation. LST full-time on-site personnel at your hospital will consist of a nurse manager and certified technicians to operate the unit during normal business hours and to provide off-hours emergency services.
Most Profitable Hyperbaric Medicine and Chronic Wound Care Program available
Fixed-Price and Zero Risk Contract Performance Structure protects both parties
Positive Cash-flow within 60 days with no direct startup charges to Hospital
LST Contracts meet STARK regulations, CMS, JCAHO and OIG Guidelines
National Board Certified Hyperbaric and EMT trained Technicians
LST is an International Leader in Chronic Wound & Hyperbaric Technologies
LST Staff are active members of the international UHMS, NFPA, and ASME Safety
LST Patented LASER Targeted Digital Camera wound documentation system
Computer-based Patient Wound care and HBOT Treatment Tracking System
How your hospital will benefit from a Hyperbaric Medicine Program
In this era of rapidly changing medical service reimbursement, most Article-28 medical institutions are seeking to develop new profit centers that are clinically effective, involve minimal risk, and that fit within the overall goals of the hospital while meeting community needs.
The need for a clinically effective chronic wound treatment service is evident in any community, especially in areas with older patient populations. Advancements in chronic wound treatment technology, particularly in the adjunctive use of Hyperbaric Oxygen Therapy (HBOT) have dramatically improved the resolution rates of even the most refractory chronic wounds.
The timely use of adjunctive HBOT can often significantly delay or even eliminate the need for limb amputations over a patient lifetime while actually increasing the total numbers of vascular and other surgical interventions needed for wound debridement, vascular by-pass, and reconstructive graft and flap surgeries in the same patient population.
Our equipment package includes two temperature controlled BARA-MED monoplace hyperbaric chambers and patented ancillary support equipment necessary to connect to the hospitals existing air and cryogenic oxygen supply systems, computer-based documentation system with complete protocols, patient data and digital photography for wound documentation.
What is Hyperbaric Oxygen Therapy?
Hyperbaric Oxygen is a FDA-approved medical therapy modality wherein the patient breathes 100% oxygen at absolute pressures that are two to three times greater than normal atmospheric pressure. This is a systemic delivery of oxygen that produces up to a 22-fold increase in arterial plasma oxygen concentration.
This produces arterial oxygen tensions of up to 2,000 mmHg, which increases the diffusion distance from functioning capillaries by up to 6 times. HBOT is not to be confused with “topical” oxygen delivery using a box or tent arrangement, which is neither FDA approved nor reimbursed by CMS.
The Undersea and Hyperbaric Medical Society has developed a list of medical indications where HBOT is considered the Standard of Care, or where HBO has demonstrated efficacy as an adjunctive treatment. The use of HBOT in these indications is Medicare and commercially reimbursed.
Standard of Care
Acute Severe Carbon Monoxide Poisoning; includes smoke inhalation, cyanide poisoning
Chronic Osteomyelitis, refractory to bone cultured antibiotics and debridement
Cerebral Arterial Gas Embolism; diver decompression or surgically induced
Radiation Tissue Injury; bone and soft tissue complications
Decompression Sickness; systemic inert gas (nitrogen) bubbles
Gas Gangrene; Clostridial myonecrosis and myositis
Osteoradionecrosis, particularly of the mandible
Standard of Care
Enhancement of Healing; select hypoxic wounds compromised grafts and flaps
Exceptional Blood Loss Anemia; patient refusal of blood, difficult cross matching
Diabetic Ulcers; Wagner grade 3+ that have failed 30 days conventional therapy
Necrotizing Soft Tissue Infections; subcutaneous tissue, muscle, fascia
Crush Injury; compartment syndrome and other acute ischemia
Thermal Burns; acute management, reduces need for fluid resuscitation
Intracranial Brain Abscess; including subdural and epidural empyema
On the Horizon
Investigational indications for HBOT include the treatment of myocardial infarction in conjunction with clot-dissolving drugs such as TPA. Institutional research presently underway includes the adjunctive use of HBOT in cases of cardiovascular accidents, traumatic brain injury, spinal cord injury, HIV, Cerebral Palsy and refractory Lyme disease.